1. Home
  2. JAZZ vs ASR Comparison

JAZZ vs ASR Comparison

Compare JAZZ & ASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$195.37

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Grupo Aeroportuario del Sureste S.A. de C.V.

ASR

Grupo Aeroportuario del Sureste S.A. de C.V.

HOLD

Current Price

$341.65

Market Cap

9.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
ASR
Founded
2003
1996
Country
Ireland
Mexico
Employees
N/A
1936
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
9.8B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
JAZZ
ASR
Price
$195.37
$341.65
Analyst Decision
Strong Buy
Buy
Analyst Count
13
4
Target Price
$216.92
$365.00
AVG Volume (30 Days)
734.6K
72.5K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
N/A
10.88%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,618,693,000.00
N/A
Revenue This Year
$6.13
$8.14
Revenue Next Year
$7.75
$9.05
P/E Ratio
N/A
$18.58
Revenue Growth
N/A
N/A
52 Week Low
$98.96
$275.83
52 Week High
$200.24
$381.52

Technical Indicators

Market Signals
Indicator
JAZZ
ASR
Relative Strength Index (RSI) 62.93 50.94
Support Level $159.78 $317.21
Resistance Level $198.00 $348.98
Average True Range (ATR) 4.90 10.52
MACD 0.74 2.43
Stochastic Oscillator 75.11 54.12

Price Performance

Historical Comparison
JAZZ
ASR

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About ASR Grupo Aeroportuario del Sureste S.A. de C.V.

Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.

Share on Social Networks: